Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool December 6, 2005 Stephen D. Simpson	Diving Into the Dow: The Final Five The authors banter about the relative merits and investment opportunities of some the biggest companies in America: AT&T... United Technologies... Verizon Communications... Wal-Mart ... Disney...
The Motley Fool March 18, 2009 Brian Orelli	Merck Pummels Pfizer One of these acquisitions is not like the other.
The Motley Fool November 7, 2011 Tamara Rutter	It Pays to Invest Like a Dog Find out how the Dow's best dividend stocks can work for you.
The Motley Fool November 18, 2005 Stephen D. Simpson	Diving Into the Dow: The Fourth Five The authors banter about the relative merits and investment opportunities of some the biggest companies in America: Honeywell International... Intel... IBM... Johnson & Johnson... JPMorgan Chase...
The Motley Fool December 13, 2011 Brian Orelli	Dividend? Buyback? Here's How to Get Both. But will there be enough to replenish the pipeline?
The Motley Fool January 19, 2007 Ryan Fuhrmann	The Best Drug Stock for 2007: Pfizer Investors, this is a great company at a great price.
The Motley Fool June 9, 2006 Nathan Parmelee	Are You Prepared for Volatility? Investors, here's how to use the market's ups and downs to your advantage.
The Motley Fool February 22, 2005 Charly Travers	Is Big Pharma a Bargain? While much of the drug sector is looking pretty tasty, Pfizer, with its attractive relative valuation, dominant marketing presence, and willingness to buy up blockbuster drugs, heads the list.
The Motley Fool November 11, 2005 Simpson & Parmelee	Diving Into the Dow: The Second Five The authors banter about the relative merits and investment opportunities of some the biggest companies in America: Altria Group... Caterpillar... Citigroup... Coca-Cola... DuPont...
The Motley Fool February 22, 2007 Ryan Fuhrmann	Dueling Fools: Pfizer Bull The drug giant has ample firepower. The current company valuation largely ignores Pfizer's upside potential past 2008.
The Motley Fool June 13, 2006 Steven Mallas	Stocks Worth Shopping For A trip to the store might be the easiest way to get started investing. Coca-Cola... PepsiCo... Procter & Gamble... Gillette... Johnson & Johnson... etc.
The Motley Fool December 15, 2010 Esterhuizen & Sellitti	Dividend Ideas: 2011 Dogs of the Dow Sticking to this investing approach has yielded impressive gains for its proponents.
The Motley Fool August 13, 2010 Ilan Moscovitz	Procter & Gamble: Dividend Dynamo or Disaster? Just how safe is this dividend?
The Motley Fool September 29, 2010 Matt Koppenheffer	Are Stocks Actually Cheap? Is this popular signal saying that stocks are cheap right now?
The Motley Fool January 12, 2012 Brian Orelli	What to Look For From Pfizer in 2012 Leaner? Yes. Meaner? We'll see.
The Motley Fool June 11, 2008 Brian Orelli	Dueling Fools: Pfizer Bull The bullish opinion on Pfizer is that this may be the best time to buy this stock.
The Motley Fool August 29, 2008 Brian Orelli	Can Health-Care Dividends Hold Up? As many health-care companies' share prices drop, their dividend yields have become strikingly attractive. The big question, though, is whether these dividends can hold up.
The Motley Fool March 9, 2009 Brian Orelli	Merck-Schering Trumps Pfizer-Wyeth The new Merck deal looks a lot better than a combined Pfizer plus Wyeth.
The Motley Fool February 22, 2007 Brian Lawler	Dueling Fools: Pfizer Bear It's been a blue chip for years, but that doesn't mean it will stay that way forever. It's inconceivable for Pfizer's market capitalization to be valued at $188 billion four years from now, when its revenues could be 40% lower than they are today.
The Motley Fool October 12, 2005 Steven Mallas	P&G Gambles on Prosperity Shareholders will have a nice stock on their hands for a while. Procter & Gamble sees steady growth four years out.
The Motley Fool May 3, 2006 Selena Maranjian	When Dividends Are Dicey A hefty dividend yield isn't always something investors can count on.
The Motley Fool May 4, 2005 David Meier	Double Your Chances If you find high-yielding stocks at low prices, you may be on your way to beating the market.
The Motley Fool December 21, 2006 Ryan Fuhrmann	Dueling Fools: Merck Bear Investors, because of its recent run-up, the risk/reward tradeoff is not very compelling. There are safer, more lucrative ways to invest in the space.
The Motley Fool June 28, 2010 Dan Caplinger	2 Ways Dividend Stocks Can Make You Rich Before you simply pick a few for your portfolio, you need to get a grasp on one of the major differences among the thousands of stocks that pay dividends.
The Motley Fool April 27, 2007 Joe Magyer	The Weekly Dividend 'Twas a wonderful week to be a yield piggy. ExxonMobil... Procter & Gamble... IBM... etc.
The Motley Fool September 20, 2005 Steven Mallas	P&G Comes Out Clean Procter & Gamble should do fine, even with the effects of Katrina. At some point, lingering lofty fuel prices may cause havoc on the company's bottom line. If it does, you should consider buying on the dips.
The Motley Fool November 9, 2005 Simpson & Parmelee	Diving Into the Dow: The First Five The authors banter about the relative merits and investment opportunities of some of the biggest companies in America: 3M... Alcoa... American International Group... American Express... Boeing...
The Motley Fool December 21, 2006 Ryan Fuhrmann	Dueling Fools: Merck Bear Rebuttal Yes, Merck is a good company, but investors can still do better.
The Motley Fool September 2, 2005 Nathan Parmelee	3 Stocks That Can Pay More Dividend growth is as important as the dividend itself. Here are three stocks that make the dividend growth cut. Polaris Industries... Nokia... Kimberly-Clark...
The Motley Fool November 15, 2005 Stephen D. Simpson	Diving Into The Dow: The Third Five The authors banter about the relative merits and investment opportunities of some the biggest companies in America: ExxonMobil... General Electric... General Motors... Hewlett-Packard... etc.
The Motley Fool December 20, 2005	Dividend Yield Physics Why do dividend yields rise when stock prices fall? It's because of a little simple math.
The Motley Fool August 26, 2010 Jordan DiPietro	Pfizer's Dividends May Not Last Forever Pfizer, which operates in the pharmaceuticals industry, currently pays a dividend of 4.5%. But what's more important than the dividend itself is Pfizer's ability to keep that that cash rolling.
The Motley Fool April 28, 2009 Brian Orelli	The Costs of Being Pfizer With Pfizer having announced its intention to buy Wyeth this quarter, investors may have worried that the negotiating and pre-acquisition planning caused management to be distracted, but that doesn't seem to be the case.
The Motley Fool April 20, 2007 Ryan Fuhrmann	Discerning Pfizer's Pfuture The company is undergoing a transformation, but that doesn't mean it isn't worth a look from investors.
The Motley Fool January 4, 2012 Rebecca Lipman	Trading Strategy: 2012 Dogs of the Dow Are any of these names in your portfolio -- or on your watch list?
The Motley Fool December 18, 2008 Brian Orelli	Best Stock for 2009: Pfizer Pfizer's languishing stock price has made the company so much more attractive; it could see a breakout in 2009.
The Motley Fool January 13, 2005 Selena Maranjian	Big Dividend Payers Big dividend payers can reward you well, but select carefully.
The Motley Fool December 12, 2008 Rich Smith	This Just In: Upgrades and Downgrades Soleil Securities hands out "buy" ratings to Sepracor, Cephalon, Endo Pharm, and Pfizer.
The Motley Fool August 12, 2008 Andrew Sullivan	The Market Indicator You Shouldn't Ignore There's a silver lining in the market's recent slump.
The Motley Fool May 3, 2010 Alex Dumortier	4 Stocks That Are Leading the Rebound in Dividends With their April dividend raises, IBM, Johnson & Johnson, Procter & Gamble, and ExxonMobil added $1.9 billion to S&P 500 dividends
The Motley Fool June 7, 2010 Nathan Alderman	Roundtable: Best Dividend Stocks for Beginners A Foolish phalanx suggests powerful payout providers for novice investors.
The Motley Fool October 11, 2004 Roger Nusbaum	Pfizer: Prognosis Critical This American icon seems destined to lag for the forseeable future.
The Motley Fool October 24, 2005 Mathew Emmert	Dividends Go Mainstream Soaring demand among dividend-based exchange-traded funds shows that the yield is once again in vogue.
The Motley Fool May 23, 2005 John Reeves	The Best Analyst Money Can Buy One of the keys to successful investing is knowledge. For other stocks that may or may not become value opportunities in the future, it would be ideal if you did your homework ahead of time. That way, you are ready when the situation arises.
The Motley Fool October 8, 2004 Whitney Tilson	Blue-Chip Bargains? Sifting through beaten-down stocks may yield some good investments. But be careful, most of these stocks are that way for a reason.
The Motley Fool November 2, 2011 Brian Orelli	Lipitor Loss Looming, Pfizer Shines Good thing it's already priced in.
The Motley Fool September 30, 2004 W. D. Crotty	Merck Chokes Back Vioxx The $2.3 billion arthritis drug is withdrawn from the market after clinical studies point to dangerous side-effects. Despite the bad news, Merck's big dividend payouts don't appear to be in jeopardy at the moment.
The Motley Fool January 23, 2007 Ryan Fuhrmann	Pfizer Pfizzles Through 2006 The company is in a top-line pickle, but it expects things to get better. Current investors are now left standing until a rebound in growth, now targeted for 2009.
AskMen.com Terence Channon	Hot Stocks In 2008 Despite the negativity and floods of bad economic news, there are always opportunities in the market. Here are a handful of hot stocks that may be poised to outperform the stock market in 2008, regardless of recession possibilities.
The Motley Fool January 9, 2007 Selena Maranjian	How to Earn a 3,017% Return In exchange for his $35 investment in each share of Pfizer stock 47 years ago, this 98-year-old is now receiving $1,056 per share each year. That's some payback, eh?